Budesonide Oral Inhalation
221 interactions 609 cited referencesBudesonide is used to prevent difficulty breathing, chest tightness, wheezing, and coughing caused by asthma. Budesonide powder for oral inhalation (Pulmicort Flexhaler) is used in adults and children 6 years of age and older. Budesonide suspension (liquid) for oral inhalation (Pulmicort Respules) is used in children 1… Read the full Budesonide Oral Inhalation drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Budesonide Oral Inhalation Suzetrigine Journavx Reduced sensitive CYP3A substrate exposure and reduced efficacy of sensitive CYP3A substrate Details Budesonide Oral Inhalation Tazemetostat Tazverik Reduced CYP3A substrate exposure and reduced efficacy of CYP3A substrate Details Budesonide Oral Inhalation Telaprevir Increased budesonide exposure and significantly reduced serum cortisol concentrations Details Budesonide Oral Inhalation Telithromycin Increased budesonide exposure and an increased risk of budesonide-related adverse effects Details Budesonide Oral Inhalation Tenoxicam Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Tiaprofenic Acid Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Tolfenamic Acid Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Tolmetin Tolectin 600 Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Tosufloxacin An increased risk of tendon rupture Details Budesonide Oral Inhalation Trofinetide Daybue Increased CYP3A substrate exposure and an increased risk of CYP3A substrate-related toxicities Details Budesonide Oral Inhalation Troleandomycin Increased budesonide exposure Details Budesonide Oral Inhalation Tucatinib Tukysa Increased budesonide exposure Details Budesonide Oral Inhalation Upadacitinib Rinvoq Increased risk of gastrointestinal perforations Details Budesonide Oral Inhalation Valdecoxib Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Verapamil Calan Increased budesonide exposure Details Budesonide Oral Inhalation Vonoprazan Voquezna Increased budesonide exposure Details Budesonide Oral Inhalation Voriconazole Vfend Increased budesonide exposure, an increased risk of Cushing's syndrome and an increased risk of adrenal dysfunction Details Budesonide Oral Inhalation Voxelotor Oxbryta Increased budesonide exposure DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist